MARKET

GDRX

GDRX

Goodrx Holdings, Inc.
NASDAQ
7.01
-0.05
-0.71%
After Hours: 7.11 +0.1 +1.43% 19:13 03/27 EDT
OPEN
7.14
PREV CLOSE
7.06
HIGH
7.23
LOW
6.90
VOLUME
1.24M
TURNOVER
0
52 WEEK HIGH
9.37
52 WEEK LOW
4.135
MARKET CAP
2.77B
P/E (TTM)
-324.5370
1D
5D
1M
3M
1Y
5Y
While institutions invested in GoodRx Holdings, Inc. (NASDAQ:GDRX) benefited from last week's 3.1% gain, private equity firms stood to gain the most
Top 2 shareholders of GoodRx Holdings, Inc. (NASDAQ:GDRX) own 51% of the company. With a 58% stake, private equity firms possess the maximum shares in GoodRX Holdings. Institutions own 14% of Goodrx Holdings. The company has a significant amount of ownership in the company, and is owned by a number of institutions. Good rx Holdings's ownership of 58% suggests the company's owners are influenced by the larger public. It is important to understand the ownership structure of a company to understand its future growth.
Simply Wall St · 1h ago
Why GoodRx Surged Today
Wells Fargo raised its rating on GoodRX from "equal weight" to "overweight" GoodRx is a prescription drug price-comparison site and telehealth platform. The company beat expectations in its fourth-quarter report. The stock is up 7.5% today and up 28% since January.
The Motley Fool · 2d ago
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Landos Biopharma, Inc. Shares jumped 171.2% to $21.70 on Monday. AbbVie and Landos signed a definitive agreement to acquire the company. Altamira Therapeutics Ltd. Shares climbed 70.1% after falling around 22% on Friday. GameStop Corp. Shares rose 8.4% after the company announced a separation.
Benzinga · 2d ago
Wells Fargo upgrades GoodRx, stock jumps 10%
Seeking Alpha · 2d ago
Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says
Wells Fargo upgraded GoodRx Holdings Inc (NASDAQ:GDRX) from Equal Weight to Overweight. Analyst says 2024 guidance has good visibility with upside potential to both estimates & valuation multiples. Goodrx's EBITDA margins could surpass expectations in 2025.
Benzinga · 2d ago
The Latest Analyst Ratings For GoodRx Holdings
GoodRx Holdings is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. The company's average 12-month price target is $8.36. 14 analysts have provided ratings for GoodRx Holding in the past three months. The average price target has increased by 18.58% over the past year.
Benzinga · 2d ago
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Shares of Esperion Therapeutics, Inc. Rose sharply in today's pre-market trading. The German government approved legislation which legalizes the possession and cultivation of cannabis for adult use. U.S. Stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday.
Benzinga · 3d ago
GoodRx Holdings Raised to Overweight From Equal-Weight by Wells Fargo
Dow Jones · 3d ago
More
About GDRX
GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.

Webull offers Goodrx Holdings Inc stock information, including NASDAQ: GDRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GDRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GDRX stock methods without spending real money on the virtual paper trading platform.